GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 94 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2021. The put-call ratio across all filers is 1.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,100 | -37.7% | 21,570 | -29.4% | 0.00% | 0.0% |
| Q2 2023 | $59,567 | -29.9% | 30,547 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $84,921 | -19.4% | 30,547 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $105,387 | -85.0% | 30,547 | -44.2% | 0.00% | -88.9% |
| Q4 2021 | $703,000 | +48.6% | 54,700 | +24.9% | 0.02% | +100.0% |
| Q3 2021 | $473,000 | -19.3% | 43,800 | -31.7% | 0.01% | -18.2% |
| Q2 2021 | $586,000 | -7.1% | 64,167 | -4.1% | 0.01% | 0.0% |
| Q1 2021 | $631,000 | +140.8% | 66,927 | +0.7% | 0.01% | +120.0% |
| Q4 2020 | $262,000 | +33.7% | 66,467 | -10.2% | 0.01% | -16.7% |
| Q3 2020 | $196,000 | +51.9% | 74,056 | +282.5% | 0.01% | 0.0% |
| Q2 2020 | $129,000 | – | 19,363 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,102,929 | $18,059,047,000 | 4.95% |
| Svennilson Peter | 3,102,934 | $18,059,000 | 2.29% |
| Casdin Capital, LLC | 2,270,000 | $13,211,000 | 1.40% |
| FRAZIER MANAGEMENT LLC | 2,061,758 | $11,999,000 | 1.36% |
| Redmile Group, LLC | 3,068,194 | $17,857,000 | 0.50% |
| Alphabet Inc. | 929,022 | $5,407,000 | 0.36% |
| Bleichroeder LP | 169,039 | $984,000 | 0.26% |
| Leap Investments LP | 14,400 | $84,000 | 0.12% |
| DAFNA Capital Management LLC | 50,000 | $291,000 | 0.12% |
| Blackstone Inc. | 2,567,445 | $14,943,000 | 0.11% |